2018
DOI: 10.1016/j.bbmt.2017.12.115
|View full text |Cite
|
Sign up to set email alerts
|

Mesenchymal Stem Cell Infusion in Haploidentical Hematopoietic Stem Cell Transplantation in Patients with Hematological Malignancies

Abstract: Conclusion: In this limited set of patients with T-Cell malignancy and in a subset with T-Cell Lymphoma, overall survival after autologous and allogeneic HCT appears equivalent to published series utilizing conventional conditioning regimens. We conclude that FBT might offer certain patients an alternative conditioning regimen whose co-morbid status places them at risk for TRM from conventional regimens.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
references
References 0 publications
0
0
0
Order By: Relevance